comparemela.com

Page 8 - Nyse Elv News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Wedge Capital Management L L P NC Trims Stock Position in Elevance Health, Inc (NYSE:ELV)

Wedge Capital Management L L P NC lowered its stake in shares of Elevance Health, Inc. (NYSE:ELV – Free Report) by 4.3% in the fourth quarter, according to its most recent 13F filing with the SEC. The fund owned 63,606 shares of the company’s stock after selling 2,863 shares during the period. Wedge Capital Management […]

Elevance Health, Inc (NYSE:ELV) Shares Sold by Signaturefd LLC

Signaturefd LLC lessened its stake in Elevance Health, Inc. (NYSE:ELV – Free Report) by 1.5% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 4,033 shares of the company’s stock after selling 62 shares during the period. Signaturefd LLC’s holdings in […]

Elevance Health (NYSE:ELV) Issues Earnings Results

Elevance Health (NYSE:ELV – Get Free Report) released its quarterly earnings results on Thursday. The company reported $10.64 EPS for the quarter, topping analysts’ consensus estimates of $10.54 by $0.10, Briefing.com reports. The company had revenue of $42.27 billion for the quarter, compared to analyst estimates of $42.49 billion. Elevance Health had a return on […]

Elevance Health, Inc (NYSE:ELV) Shares Purchased by Sumitomo Mitsui DS Asset Management Company Ltd

Sumitomo Mitsui DS Asset Management Company Ltd increased its stake in shares of Elevance Health, Inc. (NYSE:ELV – Free Report) by 3.4% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 24,604 shares of the company’s stock after purchasing an additional […]

Elevance Health (NYSE:ELV) Price Target Increased to $621 00 by Analysts at Barclays

Elevance Health (NYSE:ELV – Free Report) had its target price hoisted by Barclays from $584.00 to $621.00 in a research report released on Friday morning, Benzinga reports. They currently have an overweight rating on the stock. ELV has been the topic of a number of other research reports. Wells Fargo & Company dropped their target […]

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.